Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size

Background. To explore the effect of atropine 0.01% on accommodation functions and pupil size for safely and effectively controlling myopia in Chinese children. Methods. This was a single-center randomized clinical trial. 63 participants with myopia of at least −0.50 D and astigmatism of ≤−2.50 D we...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuliang Wang, Jing Yao, Xiaomei Qu
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2020/7525180
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551018822369280
author Yuliang Wang
Jing Yao
Xiaomei Qu
author_facet Yuliang Wang
Jing Yao
Xiaomei Qu
author_sort Yuliang Wang
collection DOAJ
description Background. To explore the effect of atropine 0.01% on accommodation functions and pupil size for safely and effectively controlling myopia in Chinese children. Methods. This was a single-center randomized clinical trial. 63 participants with myopia of at least −0.50 D and astigmatism of ≤−2.50 D were enrolled and randomized to receive atropine 0.01% once nightly with regular single-vision lenses or to wear regular single-vision lenses, in an allocation ratio of 3 : 2. Primary outcomes included changes of accommodation functions, pupil diameter, distant and near best-corrected visual acuity (BCVA), near stereoacuity, and intraocular pressure (IOP). Secondary outcome was myopic progression at 6 months. Results. 61 participants completed the follow-up. Compared with the control group, the atropine-treated children showed a statistically significant increase in pupil diameter after 6 months (0.7 ± 0.7 vs. 0.1 ± 0.5 mm, P=0.01). Despite the enlarged pupil, routine vision-related activities were not affected. The mean changes in accommodative functions, BCVA, near stereoacuity, and IOP, did not differ significantly between the groups. At 6 months, participants in the control group showed greater myopia progression than those in the atropine group (spherical equivalent: −0.60 ± 0.43 vs.−0.30 ± 0.42 D, P<0.001; axial length: 0.35 ± 0.20 vs. 0.24 ± 0.16 mm, P=0.001). Conclusions. Atropine 0.01% eye drops significantly increased pupil diameter less than one mm, but it did not affect accommodative functions, BCVA, near stereoacuity, and IOP. Combined with its reducing myopia progression, atropine 0.01% can be used as a safe and effective treatment for myopia in Chinese children.
format Article
id doaj-art-faa65a3b62c24190aab7eb4bb37f5727
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-faa65a3b62c24190aab7eb4bb37f57272025-02-03T06:05:14ZengWileyJournal of Ophthalmology2090-004X2090-00582020-01-01202010.1155/2020/75251807525180Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil SizeYuliang Wang0Jing Yao1Xiaomei Qu2Department of Ophthalmology and Vision Science, Eye & ENT Hospital, Fudan University, Shanghai, ChinaDepartment of Ophthalmology and Vision Science, Eye & ENT Hospital, Fudan University, Shanghai, ChinaDepartment of Ophthalmology and Vision Science, Eye & ENT Hospital, Fudan University, Shanghai, ChinaBackground. To explore the effect of atropine 0.01% on accommodation functions and pupil size for safely and effectively controlling myopia in Chinese children. Methods. This was a single-center randomized clinical trial. 63 participants with myopia of at least −0.50 D and astigmatism of ≤−2.50 D were enrolled and randomized to receive atropine 0.01% once nightly with regular single-vision lenses or to wear regular single-vision lenses, in an allocation ratio of 3 : 2. Primary outcomes included changes of accommodation functions, pupil diameter, distant and near best-corrected visual acuity (BCVA), near stereoacuity, and intraocular pressure (IOP). Secondary outcome was myopic progression at 6 months. Results. 61 participants completed the follow-up. Compared with the control group, the atropine-treated children showed a statistically significant increase in pupil diameter after 6 months (0.7 ± 0.7 vs. 0.1 ± 0.5 mm, P=0.01). Despite the enlarged pupil, routine vision-related activities were not affected. The mean changes in accommodative functions, BCVA, near stereoacuity, and IOP, did not differ significantly between the groups. At 6 months, participants in the control group showed greater myopia progression than those in the atropine group (spherical equivalent: −0.60 ± 0.43 vs.−0.30 ± 0.42 D, P<0.001; axial length: 0.35 ± 0.20 vs. 0.24 ± 0.16 mm, P=0.001). Conclusions. Atropine 0.01% eye drops significantly increased pupil diameter less than one mm, but it did not affect accommodative functions, BCVA, near stereoacuity, and IOP. Combined with its reducing myopia progression, atropine 0.01% can be used as a safe and effective treatment for myopia in Chinese children.http://dx.doi.org/10.1155/2020/7525180
spellingShingle Yuliang Wang
Jing Yao
Xiaomei Qu
Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size
Journal of Ophthalmology
title Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size
title_full Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size
title_fullStr Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size
title_full_unstemmed Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size
title_short Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size
title_sort atropine 0 01 for the control of myopia in chinese children effect on accommodation functions and pupil size
url http://dx.doi.org/10.1155/2020/7525180
work_keys_str_mv AT yuliangwang atropine001forthecontrolofmyopiainchinesechildreneffectonaccommodationfunctionsandpupilsize
AT jingyao atropine001forthecontrolofmyopiainchinesechildreneffectonaccommodationfunctionsandpupilsize
AT xiaomeiqu atropine001forthecontrolofmyopiainchinesechildreneffectonaccommodationfunctionsandpupilsize